RE:Today's Call They said they were pleased with the results so far (or something like that) and they will no longer make comments such as @exceeding expectations!!
Which also means I think that they will not disclose in future PR s if NOT meeting expectations
TechOne wrote: I did not listen to it so what I have summarized from posts here so please tell me know I got it.. Or not..
1. Baxter made the extension deal and paid the 2nd milestone, CAD $ 2M without looking at the intrim data.
2. Baxter will wait till they get the numbers when the trial is completed. Does not want data leak or any issue with FDA regarding the trial..
3. Spectral still needs $17-18 M to take the trial to conclusion etc. etc.
So hence, no firework in POS and we are still on the same trajectory of slow burn for next few months until it is all done..
Does that cover it or did I miss something.. Thanks..